UBS Starts Walgreens Boosts Alliance (WBA) at Buy

October 6, 2016 6:58 AM EDT
Get Alerts WBA Hot Sheet
Price: $81.88 -1.93%

Rating Summary:
    21 Buy, 11 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 29 | Down: 29 | New: 23
Trade WBA Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

UBS initiates coverage on Walgreens Boosts Alliance (NASDAQ: WBA) with a Buy rating and a price target of $94.00.

Analyst Michael Cherny commented, "We are initiating coverage of Walgreens Boots Alliance with a Buy rating and a $94 price target. Walgreens is one of the two largest drug retailers in the US as well as the leading European drug retailer, with a focus on offering a combination of both convenience and differentiated products (including the No7 beauty products from Boots). The company is also in the midst of broadening its channel partnerships through a number of agreements with various different supply chain constituents, all targeted at driving improved productivity of the “box.” Note: UBS is acting as financial advisor to Walgreens in its pending acquisition of Rite Aid."

For an analyst ratings summary and ratings history on Walgreens Boosts Alliance click here. For more ratings news on Walgreens Boosts Alliance click here.

Shares of Walgreens Boosts Alliance closed at $80.51 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage

Related Entities

UBS, Definitive Agreement

Add Your Comment